Chander S - Search Results

1

Protein-Based Nanohydrogels for Bioactive Delivery.

Chander S, Kulkarni GT, Dhiman N, Kharkwal H. Chander S, et al. Front Chem. 2021 Jul 9;9:573748. doi: 10.3389/fchem.2021.573748. eCollection 2021. Front Chem. 2021. PMID: 34307293 Free PMC article. Review.

2

Search for new therapeutics against HIV-1 via dual inhibition of RNase H and integrase: current status and future challenges.

Kharkwal H, Kumar BK, Murugesan S, Singhvi G, Avasthi P, Goyal A, Jamalis J, Chander S. Kharkwal H, et al. Among authors: chander s. Future Med Chem. 2021 Feb;13(3):269-286. doi: 10.4155/fmc-2020-0257. Epub 2021 Jan 5. Future Med Chem. 2021. PMID: 33399497 Review.

3

Potential inhibitory activity of phytoconstituents against black fungus: In silico ADMET, molecular docking and MD simulation studies.

Hamaamin Hussen N, Hameed Hasan A, Jamalis J, Shakya S, Chander S, Kharkwal H, Murugesan S, Ajit Bastikar V, Pyarelal Gupta P. Hamaamin Hussen N, et al. Among authors: chander s. Comput Toxicol. 2022 Nov;24:100247. doi: 10.1016/j.comtox.2022.100247. Epub 2022 Sep 24. Comput Toxicol. 2022. PMID: 36193218 Free PMC article.

4

Spotlight on 4-substituted quinolines as potential anti-infective agents: Journey beyond chloroquine.

Goyal A, Kharkwal H, Piplani M, Singh Y, Murugesan S, Aggarwal A, Kumar P, Chander S. Goyal A, et al. Among authors: chander s. Arch Pharm (Weinheim). 2023 Mar;356(3):e2200361. doi: 10.1002/ardp.202200361. Epub 2022 Dec 9. Arch Pharm (Weinheim). 2023. PMID: 36494101 Review.

5

Anti-infective Potential of Manzamine Alkaloids - A Review.

Ashok P, Faheem, Kumar BK, Chander S, Chandra Sekhar KVG, Sankaranarayanan M. Ashok P, et al. Among authors: chander s. Med Chem. 2022;18(6):629-654. doi: 10.2174/1573406417666210803101740. Med Chem. 2022. PMID: 34344295 Review.

6

Novel thiophene Chalcones-Coumarin as acetylcholinesterase inhibitors: Design, synthesis, biological evaluation, molecular docking, ADMET prediction and molecular dynamics simulation.

Hasan AH, Murugesan S, Amran SI, Chander S, Alanazi MM, Hadda TB, Shakya S, Pratama MRF, Das B, Biswas S, Jamalis J. Hasan AH, et al. Among authors: chander s. Bioorg Chem. 2022 Feb;119:105572. doi: 10.1016/j.bioorg.2021.105572. Epub 2021 Dec 21. Bioorg Chem. 2022. PMID: 34971946

7

Medicinal chemistry perspectives of 1,2,3,4-tetrahydroisoquinoline analogs - biological activities and SAR studies.

Faheem, Karan Kumar B, Chandra Sekhar KVG, Chander S, Kunjiappan S, Murugesan S. Faheem, et al. Among authors: chander s. RSC Adv. 2021 Mar 29;11(20):12254-12287. doi: 10.1039/d1ra01480c. eCollection 2021 Mar 23. RSC Adv. 2021. PMID: 35423735 Free PMC article. Review.

8

1,2,3,4-Tetrahydroisoquinoline (THIQ) as privileged scaffold for anticancer de novo drug design.

Faheem, Karan Kumar B, Venkata Gowri Chandra Sekhar K, Chander S, Kunjiappan S, Murugesan S. Faheem, et al. Among authors: chander s. Expert Opin Drug Discov. 2021 Oct;16(10):1119-1147. doi: 10.1080/17460441.2021.1916464. Epub 2021 Apr 28. Expert Opin Drug Discov. 2021. PMID: 33908322 Review.

9

Design, synthesis of new β-carboline derivatives and their selective anti-HIV-2 activity.

Ashok P, Chander S, Balzarini J, Pannecouque C, Murugesan S. Ashok P, et al. Among authors: chander s. Bioorg Med Chem Lett. 2015 Mar 15;25(6):1232-5. doi: 10.1016/j.bmcl.2015.01.058. Epub 2015 Jan 30. Bioorg Med Chem Lett. 2015. PMID: 25682562

10

De-novo design, synthesis and evaluation of novel 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as HIV-1 reverse transcriptase inhibitors.

Chander S, Ashok P, Singh A, Murugesan S. Chander S, et al. Chem Cent J. 2015 Jun 9;9:33. doi: 10.1186/s13065-015-0111-6. eCollection 2015. Chem Cent J. 2015. PMID: 26075019 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

300 results

Search Page